Note: Ingredients listed on restricted chemical lists
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
>=0.1-<1
General Information
Version
3.1
Revision date
2025-12-25
Product name
JASCAYD (nerandomilast) tablets
Product Synonyms
BI 1015550 film-coated tablets 6 mg, BI 1015550 film-coated tablets 9 mg, BI 1015550 film-coated tablets 12 mg, BI 1015550 film-coated tablets 18 mg with active ingredient: Nerandomilast
1.2.1 Relevant identified uses
Pharmaceutical Development compound
1.2.2. Uses advised against
Safety Data Sheet only for the professional user
supplier name
Boehringer Ingelheim Pharmaceuticals Inc
Emergency telephone
+1 703-527-3887, +1 703-741-5970
Icons in SDS
Company Information
company name
Boehringer Ingelheim Pharmaceuticals Inc
e-mail address of the competent person responsible for the Safety Data Sheet
EHS-Services@Boehringer-Ingelheim.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H361, H372
Hazard statements
Code
Statements
H361
Suspected of damaging fertility or the unborn child
Section 2
SECTION 2: Hazards identification
2.3 Other hazards
This drug is not subject to the labelling requirements under the Globally Harmonized System (GHS) The pharmacological effect of the medicament has to be considered (see package leaflet). Hazards associated with a change in physical form: This product does not contain titanium dioxide in its respirable form and would not be considered carcinogenic; however, upon crushing, grinding or other processing that could result in the gener- ation of respirable particulates, the Category 2 carcinogenic classification would apply.
Signal word
Danger
Hazard statements
H361 Suspected of damaging fertility or the unborn child. H372 Causes damage to organs (Heart, Bone) through pro- longed or repeated exposure if swallowed.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection.
Response
P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Storage
P405 Store locked up.
Disposal
P501 Dispose of contents/ container to an approved waste dis- posal plant.
Ingredient(s) with unknown acute toxicity
2.92 %
2.1 Classification of the substance or mixture
1910.1200) Hazards for the product as supplied Reproductive toxicity : Category 2 Specific target organ toxicity : Category 1 (Heart, Bone) - repeated exposure (Oral) Other hazards This drug is not subject to the labelling requirements under the Globally Harmonized System (GHS) The pharmacological effect of the medicament has to be considered (see package leaflet). Hazards associated with a change in physical form: This product does not contain titanium dioxide in its respirable form and would not be considered carcinogenic; however, upon crushing, grinding or other processing that could result in the gener- ation of respirable particulates, the Category 2 carcinogenic classification would apply.
